InsiderTrades.com logo
Healthcare Takes A Big Step Forward With The Help of A.I.
From Wall Street Star   |   Ad
To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.
Click here to learn more about the booming eHealth industry - and see which microcap will be at the
Thomas J. Healy net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Thomas Healy Biography and Net Worth

CEO of Hyliion
Thomas Healy: Mr. Healy has served as Chief Executive Officer of Hyliion since January 26, 2016. Mr. Healy holds a B.S. degree in Mechanical Engineering with a double-major in Engineering and Public Policy from Carnegie Mellon University.

What is Thomas J. Healy's net worth?

The estimated net worth of Thomas J. Healy is at least $92.19 million as of November 14th, 2023. Mr. Healy owns 33,282,551 shares of Hyliion stock worth more than $92,192,666 as of December 18th. This net worth evaluation does not reflect any other investments that Mr. Healy may own. Additionally, Mr. Healy receives a salary of $650,000.00 as CEO at Hyliion. Learn More about Thomas J. Healy's net worth.

How old is Thomas J. Healy?

Mr. Healy is currently 31 years old. There are 3 older executives and no younger executives at Hyliion. Learn More on Thomas J. Healy's age.

What is Thomas J. Healy's salary?

As the CEO of Hyliion Holdings Corp., Mr. Healy earns $650,000.00 per year. Learn More on Thomas J. Healy's salary.

How do I contact Thomas J. Healy?

The corporate mailing address for Mr. Healy and other Hyliion executives is 5100 W. 115TH PLACE, LEAWOOD KS, 66211. Hyliion can also be reached via phone at (833) 495-4466 and via email at [email protected]. Learn More on Thomas J. Healy's contact information.

Has Thomas J. Healy been buying or selling shares of Hyliion?

Thomas J. Healy has not been actively trading shares of Hyliion during the past quarter. Learn More on Thomas J. Healy's trading history.

Who are Hyliion's active insiders?

Hyliion's insider roster includes Sherri Baker (CFO), Dennis Gallagher (COO), Thomas Healy (CEO), Howard Jenkins (Director), Robert Knight, Jr. (Director), Edward Olkkola (Director), Jose Oxholm (VP), and Stephen Pang (Director). Learn More on Hyliion's active insiders.

Are insiders buying or selling shares of Hyliion?

During the last twelve months, Hyliion insiders bought shares 3 times. They purchased a total of 90,000 shares worth more than $220,100.00. During the last twelve months, insiders at the sold shares 1 times. They sold a total of 65,000 shares worth more than $253,500.00. The most recent insider tranaction occured on November, 22nd when Director Vincent T Cubbage sold 65,000 shares worth more than $253,500.00. Insiders at Hyliion own 20.4% of the company. Learn More about insider trades at Hyliion.

Information on this page was last updated on 11/22/2024.

Thomas J. Healy Insider Trading History at Hyliion

See Full Table

Thomas J. Healy Buying and Selling Activity at Hyliion

This chart shows Thomas J. Healy's buying and selling at Hyliion by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hyliion Company Overview

Hyliion logo
Hyliion Holdings Corp. engages in the design, development, and sale of power generators for stationary and mobile applications in the United States. It offers KARNO generator system, a fuel-agnostic power generation solution. The company was founded in 2015 and is headquartered in Cedar Park, Texas.
Read More

Today's Range

Now: $2.77
Low: $2.73
High: $2.91

50 Day Range

MA: $2.86
Low: $2.29
High: $3.84

2 Week Range

Now: $2.77
Low: $0.62
High: $4.09

Volume

1,364,385 shs

Average Volume

1,017,415 shs

Market Capitalization

$481.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03
Healthcare Takes A Big Step Forward With The Help of A.I.
From Wall Street Star   |   Ad
To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.
Click here to learn more about the booming eHealth industry - and see which microcap will be at the